Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-25 of 80 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

A novel heterozygous likely pathogenic SLC5A2 variant in a diabetic patient with glucosuria and aminoaciduria.
Inthasot S, Vanderhulst J, Janssens P, Van Daele S, Van Hoof E, Kint C, Iconaru L, de Filette J
Endocrinol Diabetes Metab Case Rep, 2024(3):24-65, 01 Jul 2024
Cited by: 0 articles | PMID: 39342974 | PMCID: PMC11466272
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Benatar M, Hansen T, Rom D, Geist MA, Blaettler T, Camu W, Kuzma-Kozakiewicz M, van den Berg LH, Morales RJ, Chio A, Andersen PM, Pradat PF, Lange D, Van Damme P, Mora G, Grudniak M, Elliott M, Petri S, Olney N, [...] ORARIALS-01 trial team
Lancet Neurol, 23(7):687-699, 20 May 2024
Cited by: 3 articles | PMID: 38782015
Add to export list
A Case of Chorea with Slow Saccades Caused by NKX2-1 Mutation.
Vercammen J, Terryn J, Van Daele S, Vermeer S, Vandenberghe W
Mov Disord Clin Pract, 11(6):738-741, 07 Mar 2024
Cited by: 0 articles | PMID: 38454250
Add to export list
The sense of antisense therapies in ALS.
Van Daele SH, Masrori P, Van Damme P, Van Den Bosch L
Trends Mol Med, 30(3):252-262, 11 Jan 2024
Cited by: 8 articles | PMID: 38216448
Add to export list Review
[Role of nurses specializing in oncology to support the care journey for patients with penile cancer].
De Keyser C, Fele I, Van Daele S, Diamand R, Peltier A, Roumeguère T
Prog Urol, 33(12):576-579, 01 Nov 2023
Cited by: 0 articles | PMID: 38783763
Add to export list
The roles and experiences of adolescents with cystic fibrosis and their parents during transition: A qualitative interview study.
Wyngaert KV, Debulpaep S, Van Biesen W, Van Daele S, Braun S, Chambaere K, Beernaert K
J Cyst Fibros, 23(3):512-518, 13 Oct 2023
Cited by: 0 articles | PMID: 37839982
Add to export list
Genetic variability in sporadic amyotrophic lateral sclerosis.
Van Daele SH, Moisse M, van Vugt JJFA, Zwamborn RAJ, van der Spek R, van Rheenen W, Van Eijk K, Kenna K, Corcia P, Vourc'h P, Couratier P, Hardiman O, McLaughin R, Gotkine M, Drory V, Ticozzi N, Silani V, Ratti A, de Carvalho M, [...] Van Damme P
Brain, 146(9):3760-3769, 01 Sep 2023
Cited by: 13 articles | PMID: 37043475 | PMCID: PMC10473563
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Comparison of SARS-CoV-2 seroconversion in children with chronic diseases with healthy children and adults during the first waves of the COVID-19 pandemic.
Hoste L, Prytula A, Dehoorne J, De Bruyne R, Van Biervliet S, De Waele K, Maes E, Bordon V, Vanlander A, Claes K, Vande Walle J, Schelstraete P, Van Daele S, Haerynck F
Front Pediatr, 11:1210181, 07 Aug 2023
Cited by: 1 article | PMID: 37609364 | PMCID: PMC10440688
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The role and the composition of a liaison team to facilitate the transition of adolescents and young adults: an umbrella review.
Wyngaert KV, Nédée ML, Piessevaux O, De Martelaer T, Van Biesen W, Cocquyt V, Van Daele S, De Munter J
Eur J Pediatr, 182(4):1483-1494, 03 Feb 2023
Cited by: 0 articles | PMID: 36735061
Add to export list Review
Glycemic indices at night measured by CGM are predictive for a lower pulmonary function in adults but not in children with cystic fibrosis.
Declercq D, Helleputte S, Marchand S, Van Aken S, Van Braeckel E, Van Daele S, T'Sjoen G, Van Biervliet S, Lapauw B
J Cyst Fibros, 22(1):59-65, 06 Sep 2022
Cited by: 1 article | PMID: 36068119
Add to export list
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, [...] VALOR and OLE Working Group
N Engl J Med, 387(12):1099-1110, 01 Sep 2022
Cited by: 197 articles | PMID: 36129998
Add to export list
Urinary sodium/creatinine ratio is a predictor for fractional sodium excretion and related to age in patients with cystic fibrosis.
Declercq D, Peremans L, Glorieus M, Weygaerde YV, Schaballie H, Van Braeckel E, Snauwaert E, Van Daele S, Van Biervliet S
J Cyst Fibros, 21(2):e136-e140, 19 Nov 2021
Cited by: 0 articles | PMID: 34802939
Add to export list
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.
Hoste L, Roels L, Naesens L, Bosteels V, Vanhee S, Dupont S, Bosteels C, Browaeys R, Vandamme N, Verstaen K, Roels J, Van Damme KFA, Maes B, De Leeuw E, Declercq J, Aegerter H, Seys L, Smole U, De Prijck S, [...] Tavernier SJ
J Exp Med, 219(2):e20211381, 16 Dec 2021
Cited by: 45 articles | PMID: 34914824 | PMCID: PMC8685281
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.
Siddiqi ZA, Nowak RJ, Mozaffar T, O'Brien F, Yountz M, Patti F, REGAIN Study Group
Muscle Nerve, 64(6):662-669, 14 Oct 2021
Cited by: 11 articles | PMID: 34590717
Add to export list
RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvement.
Van Daele SH, Moisse M, Race V, Van Eesbeeck A, Keldermans L, Vermeer S, Van Esch H, Claeys KG, Van Damme P
Eur J Neurol, 29(1):345-349, 17 Sep 2021
Cited by: 1 article | PMID: 34469621 | PMCID: PMC9290118
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.
Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, Fujita KP, O'Brien FL, Booth HDE, Howard JF, REGAIN Study Group
Neurology, 96(4):e610-e618, 23 Nov 2020
Cited by: 31 articles | PMID: 33229455 | PMCID: PMC7905790
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial.
Bril V, Benatar M, Andersen H, Vissing J, Brock M, Greve B, Kiessling P, Woltering F, Griffin L, Van den Bergh P, MG0002 Investigators
Neurology, 96(6):e853-e865, 20 Nov 2020
Cited by: 67 articles | PMID: 33219142 | PMCID: PMC8105899
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Long-term use of tube feeding in children with cystic fibrosis: results from two Belgian CF centers.
Declercq D, Huysentruyt K, Hauser B, De Wachter E, Van Daele S, De Baets F, Van Biervliet S
Eur J Clin Nutr, 75(4):620-627, 19 Oct 2020
Cited by: 1 article | PMID: 33077878
Add to export list
Diagnostic yield of testing for RFC1 repeat expansions in patients with unexplained adult-onset cerebellar ataxia.
Van Daele SH, Vermeer S, Van Eesbeeck A, Lannoo L, Race V, van Damme P, Claeys K, Vandenberghe W
J Neurol Neurosurg Psychiatry, 91(11):1233-1234, 30 Jul 2020
Cited by: 6 articles | PMID: 32732387
Add to export list
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Mantegazza R, O'Brien FL, Yountz M, Howard JF, REGAIN study group
Ann Clin Transl Neurol, 7(8):1327-1339, 22 Jul 2020
Cited by: 17 articles | PMID: 32700461 | PMCID: PMC7448154
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Sodium Status and Replacement in Children and Adults Living with Cystic Fibrosis: A Narrative Review.
Declercq D, Van Braeckel E, Marchand S, Van Daele S, Van Biervliet S
J Acad Nutr Diet, 120(9):1517-1529, 14 Jul 2020
Cited by: 4 articles | PMID: 32680818
Add to export list Review
'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
Vissing J, Jacob S, Fujita KP, O'Brien F, Howard JF, REGAIN study group
J Neurol, 267(7):1991-2001, 18 Mar 2020
Cited by: 28 articles | PMID: 32189108 | PMCID: PMC7320935
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study.
Murai H, Uzawa A, Suzuki Y, Imai T, Shiraishi H, Suzuki H, Okumura M, O'Brien F, Wang JJ, Fujita KP, Utsugisawa K, REGAIN Study Group
J Neurol Sci, 407:116419, 03 Aug 2019
Cited by: 9 articles | PMID: 31698177
Add to export list
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF, REGAIN Study Group
Qual Life Res, 28(8):2255, 01 Aug 2019
Cited by: 0 articles | PMID: 31115842 | PMCID: PMC6620249
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF, REGAIN Study Group
Qual Life Res, 28(8):2247-2254, 23 Mar 2019
Cited by: 23 articles | PMID: 30905021 | PMCID: PMC6620379
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 80 results

1 2 3 Next ...

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

A novel heterozygous likely pathogenic SLC5A2 variant in a diabetic patient with glucosuria and aminoaciduria.

Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

A Case of Chorea with Slow Saccades Caused by NKX2-1 Mutation.

The sense of antisense therapies in ALS.

[Role of nurses specializing in oncology to support the care journey for patients with penile cancer].

The roles and experiences of adolescents with cystic fibrosis and their parents during transition: A qualitative interview study.

Genetic variability in sporadic amyotrophic lateral sclerosis.

Comparison of SARS-CoV-2 seroconversion in children with chronic diseases with healthy children and adults during the first waves of the COVID-19 pandemic.

The role and the composition of a liaison team to facilitate the transition of adolescents and young adults: an umbrella review.

Glycemic indices at night measured by CGM are predictive for a lower pulmonary function in adults but not in children with cystic fibrosis.

Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.

Urinary sodium/creatinine ratio is a predictor for fractional sodium excretion and related to age in patients with cystic fibrosis.

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.

Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.

RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvement.

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial.

Long-term use of tube feeding in children with cystic fibrosis: results from two Belgian CF centers.

Diagnostic yield of testing for RFC1 repeat expansions in patients with unexplained adult-onset cerebellar ataxia.

Consistent improvement with eculizumab across muscle groups in myasthenia gravis.

Sodium Status and Replacement in Children and Adults Living with Cystic Fibrosis: A Narrative Review.

'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study.

Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Partnerships & funding